GPR84
Basic information
Region (hg38): 12:54362445-54364487
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPR84 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 0 | 0 |
Variants in GPR84
This is a list of pathogenic ClinVar variants found in the GPR84 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-54362807-G-A | not specified | Uncertain significance (Oct 20, 2021) | ||
12-54362810-G-A | not specified | Uncertain significance (Apr 27, 2022) | ||
12-54362842-A-G | not specified | Uncertain significance (Jan 29, 2024) | ||
12-54362896-C-T | not specified | Likely benign (Sep 03, 2024) | ||
12-54362906-T-C | not specified | Uncertain significance (Sep 04, 2024) | ||
12-54362908-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
12-54362938-C-G | not specified | Uncertain significance (Jun 29, 2023) | ||
12-54362942-C-T | not specified | Uncertain significance (Nov 12, 2024) | ||
12-54363091-A-G | not specified | Uncertain significance (Nov 19, 2022) | ||
12-54363128-C-G | not specified | Uncertain significance (Jun 03, 2024) | ||
12-54363143-G-A | not specified | Uncertain significance (Nov 06, 2023) | ||
12-54363194-C-T | not specified | Uncertain significance (Dec 03, 2024) | ||
12-54363199-C-T | not specified | Uncertain significance (Jul 14, 2024) | ||
12-54363206-T-G | not specified | Uncertain significance (Mar 02, 2023) | ||
12-54363229-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
12-54363232-C-T | not specified | Uncertain significance (Jul 27, 2024) | ||
12-54363244-C-T | not specified | Uncertain significance (May 18, 2023) | ||
12-54363245-G-A | not specified | Uncertain significance (Sep 30, 2024) | ||
12-54363284-C-G | not specified | Uncertain significance (Nov 30, 2022) | ||
12-54363326-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
12-54363338-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
12-54363356-A-G | not specified | Uncertain significance (Feb 21, 2024) | ||
12-54363362-C-T | not specified | Uncertain significance (Jan 26, 2022) | ||
12-54363664-G-T | not specified | Uncertain significance (Jul 23, 2024) | ||
12-54363668-G-A | not specified | Uncertain significance (Nov 10, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPR84 | protein_coding | protein_coding | ENST00000551809 | 1 | 2043 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.30e-9 | 0.0958 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.404 | 211 | 228 | 0.925 | 0.0000130 | 2546 |
Missense in Polyphen | 61 | 72.641 | 0.83974 | 811 | ||
Synonymous | 0.933 | 79 | 90.3 | 0.875 | 0.00000466 | 875 |
Loss of Function | -0.0188 | 13 | 12.9 | 1.01 | 9.81e-7 | 112 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for medium-chain free fatty acid (FFA) with carbon chain lengths of C9 to C14. Capric acid (C10:0), undecanoic acid (C11:0) and lauric acid (C12:0) are the most potent agonists. Not activated by short-chain and long-chain saturated and unsaturated FFAs. Activation by medium-chain free fatty acid is coupled to a pertussis toxin sensitive G(i/o) protein pathway. May have important roles in processes from fatty acid metabolism to regulation of the immune system. {ECO:0000269|PubMed:16966319}.;
- Pathway
- GPCRs, Other;Signaling by GPCR;Neutrophil degranulation;Signal Transduction;Innate Immune System;Immune System;G alpha (s) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.0863
Intolerance Scores
- loftool
- 0.765
- rvis_EVS
- 0.09
- rvis_percentile_EVS
- 60.47
Haploinsufficiency Scores
- pHI
- 0.0944
- hipred
- N
- hipred_score
- 0.197
- ghis
- 0.456
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0759
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gpr84
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;neuropeptide signaling pathway;biological_process;neutrophil degranulation
- Cellular component
- plasma membrane;integral component of plasma membrane;specific granule membrane;receptor complex;tertiary granule membrane
- Molecular function
- urotensin II receptor activity;G protein-coupled peptide receptor activity